Literature DB >> 30667466

Comparison of Clinical Care and In-Hospital Outcomes of Asian American and White Patients With Acute Ischemic Stroke.

Sarah Song1, Li Liang2, Gregg C Fonarow3, Eric E Smith4, Deepak L Bhatt5,6, Roland A Matsouaka2, Ying Xian2, Lee H Schwamm7, Jeffrey L Saver8.   

Abstract

Importance: Although overall stroke incidence and mortality in the United States is improving, little is known about the characteristics and clinical outcomes of acute ischemic stroke in Asian American individuals. Objective: To compare the characteristics, care, and outcomes of Asian American and white patients with acute ischemic stroke. Design, Setting, Participants: Retrospective analysis of Asian American and white patients admitted with a primary diagnosis of acute ischemic stroke to hospitals participating in the Get With The Guidelines-Stroke (GWTG-Stroke) program between April 1, 2004, and July 31, 2016. The GWTG-Stroke database is a prospectively collected stroke quality improvement registry sponsored by the American Heart Association/American Stroke Association. Main Outcomes and Measures: Multivariable logistic regression models assessed the association of Asian American race/ethnicity, clinical outcomes, and quality measures.
Results: The study population of 1 772 299 patients (mean [SD] age, 72.4 [14.2] years; 51.3% female) consisted of 64 337 Asian American patients (3.6%) and 1 707 962 white patients (96.4%) admitted to 2171 GWTG-Stroke hospitals with acute ischemic stroke. After adjustment for patient and hospital variables, Asian American patients were seen with greater stroke severity compared with white patients (National Institutes of Health Stroke Scale [NIHSS] score ≥16) (odds ratio [OR], 1.35; 95% CI, 1.30-1.40; P < .001), manifested higher in-hospital mortality (OR, 1.14; 95% CI, 1.09-1.19; P < .001), had longer length of stay (OR, 1.17; 95% CI, 1.14-1.20; P < .001), and were less likely to ambulate independently at discharge (OR, 0.84; 95% CI, 0.79-0.90; P < .001). Although Asian American patients had fewer intravenous tissue plasminogen activator (IV tPA) administrations than white patients (OR, 0.95; 95% CI, 0.91-0.98; P = .003), they had more symptomatic hemorrhage after tPA (OR, 1.36; 95% CI, 1.20-1.55; P < .001) and overall post-tPA complications (OR, 1.31; 95% CI, 1.18-1.46; P < .001). Asian American patients had better quality measure adherence overall than white patients, including rehabilitation (OR, 1.27; 95% CI, 1.18-1.36; P < .001), door to tPA within 60 minutes (OR, 1.14; 95% CI, 1.06-1.22; P < .001), and intensive statin therapy (OR, 1.14; 95% CI, 1.10-1.18; P < .001). After adjustment for stroke severity, Asian American patients had lower in-hospital mortality than white patients (OR, 0.95; 95% CI, 0.91-0.99; P = .008). Conclusions and Relevance: Asian American patients manifested more severe ischemic strokes, were less likely to receive IV tPA, and had worse functional outcomes than white patients. These findings warrant additional research toward improving clinical outcomes for Asian American patients with acute ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30667466      PMCID: PMC6459126          DOI: 10.1001/jamaneurol.2018.4410

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  7 in total

1.  Geographic and Regional Variability in Racial and Ethnic Disparities in Stroke Thrombolysis in the United States.

Authors:  Deji Suolang; Bridget J Chen; Nae-Yuh Wang; Rebecca F Gottesman; Roland Faigle
Journal:  Stroke       Date:  2021-10-21       Impact factor: 7.914

2.  Knowledge Gaps, Challenges, and Opportunities in Health and Prevention Research for Asian Americans, Native Hawaiians, and Pacific Islanders: A Report From the 2021 National Institutes of Health Workshop.

Authors:  Alka M Kanaya; Ann W Hsing; Sela V Panapasa; Namratha R Kandula; Maria Rosario G Araneta; Daichi Shimbo; Paul Wang; Scarlett L Gomez; Jinkook Lee; K M Venkat Narayan; Marjorie K L Mala Mau; Sonali Bose; Martha L Daviglus; Frank B Hu; Nadia Islam; Chandra L Jackson; Merle Kataoka-Yahiro; John S K Kauwe; Simin Liu; Grace X Ma; Tung Nguyen; Latha Palaniappan; V Wendy Setiawan; Chau Trinh-Shevrin; Janice Y Tsoh; Dhananjay Vaidya; Barbara Vickrey; Thomas J Wang; Nathan D Wong; Sean Coady; Yuling Hong
Journal:  Ann Intern Med       Date:  2022-01-04       Impact factor: 51.598

Review 3.  Increasing Equity While Improving the Quality of Care: JACC Focus Seminar 9/9.

Authors:  Eric C Schneider; Marshall H Chin; Garth N Graham; Lenny Lopez; Shirlene Obuobi; Thomas D Sequist; Elizabeth A McGlynn
Journal:  J Am Coll Cardiol       Date:  2021-12-21       Impact factor: 27.203

4.  [Research progress of different types of stem cells in treatment of ischemic stroke].

Authors:  Qiuzhu Chen; Ling Li; Huiqi Xie
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-01-15

5.  Lessons Learned From the Historical Trends on Thrombolysis Use for Acute Ischemic Stroke Among Medicare Beneficiaries in the United States.

Authors:  Tong Meng; Amber W Trickey; Alex H S Harris; Loretta Matheson; Sarah Rosenthal; Abd Al-Rahman Traboulsi; Jeffrey L Saver; Todd Wagner; Prasanthi Govindarajan
Journal:  Front Neurol       Date:  2022-03-04       Impact factor: 4.003

6.  Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study.

Authors:  Yang Liu; Wenxin Wang; Xuewei Huang; Xingyuan Zhang; Lijin Lin; Juan-Juan Qin; Fang Lei; Jingjing Cai; Bo Cheng
Journal:  J Diabetes       Date:  2022-08-04       Impact factor: 4.530

7.  To use stroke 911 to improve stroke awareness for countries where 911 is used as an emergency phone number.

Authors:  Renyu Liu; Jing Zhao; Xiaobin Li; Steven Messe; Marc Fisher; Anthony Rudd
Journal:  CNS Neurosci Ther       Date:  2022-08-04       Impact factor: 7.035

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.